Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: Neuroendocrine evidence for a GABA disturbance in schizophrenia
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 26 (1) , 1-9
- https://doi.org/10.1016/0165-1781(88)90081-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Effects of β-aminobutyric acid receptor agonists on the secretion of growth hormone, luteinizing hormone, adrenocorticotrophic hormone and thyroid-stimulating hormone from the rat pituitary gland in vitroJournal of Endocrinology, 1986
- γ-aminobutyric acidB receptors in the rat brain: Quantitative autoradiographic localization using [3H](−)-baclofenNeuroscience Letters, 1985
- The Two-syndrome Concept: Origins and Current StatusSchizophrenia Bulletin, 1985
- Effect of baclofen on in vitro noradrenaline release from rat hippocampus and cerebellum: an action at an α2-adrenoceptorNeurochemistry International, 1985
- Naloxone does not alter the effect of a gamma aminobutyric acid derivative, baclofen, on GH release in manJournal of Endocrinological Investigation, 1983
- Growth Hormone Responses to Apomorphine HCl in Schizophrenic Patients on Drug Holidays and at RelapseThe British Journal of Psychiatry, 1983
- Effect of γ-Aminobutyric Acid on Growth Hormone and Prolactin Secretion in Man: Influence of Pimozide and Domperidone*Journal of Clinical Endocrinology & Metabolism, 1980
- Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in manActa Endocrinologica, 1980
- (–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptorNature, 1980
- BACLOFEN IN THE TREATMENT OF SCHIZOPHRENIAThe Lancet, 1975